Experienced research teams manage DRM-associated BA/BE centers, ensuring the success and accuracy of drug research studies. They uphold research integrity, reliability, and scientific soundness, contributing to pharmaceutical science. advancement and safe medication development under the Drug Regulatory Authority.

These BA/BE centers in collaboration with DRM Pharma & Diagnostic, boast experience in successfully conducting numerous Bioavailability/Bioequivalence Studies, yielding reliable outcomes and ensuring the utmost client contentment. Through the combination of our scientific acumen and regulatory expertise, we have cultivated a deep understanding of pivotal pharmaceutical markets. DRM excels in furnishing comprehensive assistance across all stages of the study, encompassing study design, protocol implementation, and the ultimate delivery of the Study Report.

Our affiliated BA/BE (Phase-1 Study) centers have successfully developed and validated bioanalytical methods across a diverse spectrum of therapeutic areas, including: